Authors
RongLin Lai, Qi Sheng, Ming Huang, Zhongchao Zhou, Jia Liu, Liming Liu
Published in
Biotechnology advances. Pages 109048. Sep 21, 2026. Epub Sep 21, 2026.
Abstract
Branched-chain amino acids (BCAAs) are recognized not only as industrially important fermentation products but also as versatile biosynthetic platforms for the production of branched-chain value-added chemicals. The characteristic branched carbon skeletons of BCAAs, together with their metabolically versatile intermediates, enable the biosynthesis of a broad spectrum of value-added chemicals, including branched-chain α-keto acids (BCKAs), alcohols, and carboxylic acids. This review systematically examines the metabolic basis of BCAA biosynthesis and the features underpinning its platform functionality, followed by a comprehensive overview of metabolic engineering strategies for constructing efficient BCAA-producing prokaryotic cell factories. Particular emphasis is placed on bacterial production platforms, especially Escherichia coli and Corynebacterium glutamicum, in which engineering carbon flux through enhanced glucose uptake, expanded pyruvate availability, reinforced biosynthetic flux, regulated cofactor supply, and improved product export. Advances in enzyme engineering are also discussed, with four complementary strategies highlighted for expanding the branched-chain chemical repertoire: enhancement of catalytic activity, improvement of substrate selectivity, engineering of cofactor utilization through NADH regulation, and optimization of enzyme expression. Finally, current challenges and future directions are discussed, and an engineering framework is proposed for the rational development of BCAA platform-based biomanufacturing toward an expanded repertoire of branched-chain chemicals.
PMID:
42767536
Bibliographic data and abstract were imported from PubMed on 22 Sep 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 8
- Comments 0